can tirzepatide cause death after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial Tirzepatide Matches Dulaglutide in Heart

Defective amplification of the late phase insulin response to glucose by GIP in obese type II diabetic patients

Serious complications are rare but may include infection, allergic reactions, uneven fat reduction, or skin necrosis, highlighting the importance of choosing a qualified practitioner

This article will review the role of GLP-1 receptor agonists in the treatment of T2DM with a focus on the safe and appropriate use of GLP-1 analogue therapies in those with T2DM, and the instrumental role pharmacists have in ensuring that patients are adequately educated regarding these agents

Specific features of neuronal size and shape are regulated by tropomyosin isoforms

Szollosi DE, Manzoor MK, Aquilato A, Jackson P, Ghoneim OM, Edafiogho IO (2018) Current and novel anti-inflammatory drug targets for inhibition of cytokines and leucocyte recruitment in rheumatic diseases